EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Predictors of Discrepancies Between Cockcroft-Gault and Chronic Kidney Disease-EPI Creatinine-Cystatin in Hospitalized Patients

Savannah S Poole iD, Audis Bethea, Eden Brewington iD, Clifford Cornett, Jordan L Kelley, Ann Marie Stoll iD, Aric Schadler, Abigail Leonhard, Hunter Matthews, Alexandra Sutphin iD

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280251356492 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Savannah S Poole und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA. Hauptthemen laut MEDLINE: Creatinine, Renal Insufficiency, Chronic, Cystatin C, Glomerular Filtration Rate. Die Arbeit nennt 20 Literaturangaben. Gefördert von: national center for advancing translational sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cockcroft-Gault (eCrCl) remains the industry standard for estimating renal function in hospitalized patients despite known limitations. Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine-cystatin C (eGFRcr-cys) equation was developed to ameliorate these limitations and is now preferred in specific outpatient scenarios.

Objective

This study aims to determine patient-specific factors associated with a >25 milliliters per minute (mL/min) difference where eCrCl exceeds eGFRcr-cys.

Methods

This retrospective, Institutional Review Board approved, observational review included data from June 2021 to December 2022. Adults with serum cystatin C and creatinine collected within 24-hours of admission were included. Exclusions included pregnancy or renal replacement therapy. The primary endpoint was to identify patient-specific predictors of a >25 mL/min discrepancy between eCrCl and eGFRcr-cys. The secondary outcome was to determine odds ratios for identified patient-specific characteristics.

Results

Of 235 encounters, 67 had a >25 mL/min difference where eCrCl exceeded eGFRcr-cys. Multivariate regression identified the following independent predictors of this difference: age 105 kg (OR: 9.079; 95% CI: 4.344-18.978), intensive care unit (ICU) admission within 24 hours (OR 2.779; 95% CI 1.248-6.188) and diagnosis of paraplegia or quadriplegia (OR 5.490; 95% CI 1.523-19.796). Conclusion and Relevance: This study concluded that eCrCl may exceed eGFRcr-cys by >25 mL/min in patients presenting for hospital admission with one or more predictors: age 105 kg, intensive care unit (ICU) admission, or diagnosis of paraplegia or quadriplegia. Current literature suggests improved accuracy of renal clearance estimations with eGFRcr-cys. Accordingly, practitioners should consider eGFRcr-cys when evaluating new admissions with these characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CreatinineRenal Insufficiency, ChronicCystatin CGlomerular Filtration RateKidney Function TestsHumansFemaleRetrospective StudiesMaleMiddle AgedHospitalizationAgedAdult

Stichwörter der Autor:innen

Cockcroft Gaultchronic kidney disease-EPIcreatininecreatinine clearancecystatin C

Substanzen

CreatinineCystatin C

Autor:innen und Institutionen

  • Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
  • Kentucky Children's Hospital, University of Kentucky HealthCare, Lexington, KY, USA.
  • Dr. Bing Zhang Department of Statistics, University of Kentucky, Lexington, KY, USA.
  • Department of Pharmacy Services, University of Cincinnati Health, Cincinnati, OH, USA.

ORCID-Profile: Savannah S Poole, Eden Brewington, Ann Marie Stoll, Alexandra Sutphin

Förderung

  • national center for advancing translational sciences

Zitieren

APA

Poole, S. S., Bethea, A., Brewington, E., Cornett, C., Kelley, J. L., Stoll, A. M., Schadler, A., Leonhard, A., Matthews, H., & Sutphin, A. (2025). Predictors of Discrepancies Between Cockcroft-Gault and Chronic Kidney Disease-EPI Creatinine-Cystatin in Hospitalized Patients. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251356492

Vancouver

Poole SS, Bethea A, Brewington E, Cornett C, Kelley JL, Stoll AM, et al. Predictors of Discrepancies Between Cockcroft-Gault and Chronic Kidney Disease-EPI Creatinine-Cystatin in Hospitalized Patients. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251356492

BibTeX
@article{Poole2025,
  author = {Poole, Savannah S and Bethea, Audis and Brewington, Eden and Cornett, Clifford and Kelley, Jordan L and Stoll, Ann Marie and Schadler, Aric and Leonhard, Abigail and Matthews, Hunter and Sutphin, Alexandra},
  title = {Predictors of Discrepancies Between Cockcroft-Gault and Chronic Kidney Disease-EPI Creatinine-Cystatin in Hospitalized Patients},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280251356492}
}
Kostenlos starten →